Page last updated: 2024-08-25

zoledronic acid and Leucocythaemia

zoledronic acid has been researched along with Leucocythaemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Ottmann, OG; Sato, K; Segawa, H; Yuasa, T1
Colao, A; Lombardi, G; Ricci, P; Rotoli, B; Selleri, C; Serio, B; Tauchmanovà, L1

Trials

1 trial(s) available for zoledronic acid and Leucocythaemia

ArticleYear
Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:2

    Topics: Adolescent; Adult; Bone Density; Bone Marrow Cells; Diphosphonates; Female; Fibroblasts; Humans; Imidazoles; Infusions, Intravenous; Leukemia; Male; Middle Aged; Osteoporosis; Stem Cell Transplantation; Stem Cells; Transplantation, Homologous; Zoledronic Acid

2005

Other Studies

1 other study(ies) available for zoledronic acid and Leucocythaemia

ArticleYear
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.
    International journal of hematology, 2004, Volume: 79, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Division; Cell Line, Tumor; Cytarabine; Daunorubicin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydroxyurea; Imatinib Mesylate; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Pyrimidines; Vincristine; Zoledronic Acid

2004